Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA

NCT01180816 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme
Anaplastic Astrocytoma

Interventions

DRUG: Super-Selective Intraarterial Intracranial Infusion of Temozolomide

Sponsor

Northwell Health

Collaborators

[object Object]
[object Object]